Sandoz names Frederic Huser president of North American OTC business.
This article was originally published in The Tan Sheet
Executive Summary
SANDOZ CONSUMER PHARMACEUTICALS-NORTH AMERICA PRESIDENT IS FREDERIC HUSER, who joins the company from Glaxo Wellcome, where his responsibilities included North American Rx-to-OTC switch activities. Huser's appointment to the newly-created position at the head of the Sandoz OTC businesses in the U.S. and Canada becomes effective Nov. 29. He will report to Sandoz Pharmaceuticals Chief Operating Officer Mark Pulido.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning